Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

33.91
Delayed Data
As of Dec 07
 -0.91 / -2.61%
Today’s Change
8.00
Today|||52-Week Range
63.73
-12.10%
Year-to-Date
PTC Therapeutics, Inc. in 3 Charts
Dec 07 / MotleyFool.com - Paid Partner Content
Is This Why Sarepta Therapeutics Fell 14.5% in November?
Dec 05 / MotleyFool.com - Paid Partner Content
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
Dec 07 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close34.82
Today’s open34.12
Day’s range33.07 - 34.94
Volume1,547,061
Average volume (3 months)3,663,473
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+6.70%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book8.35

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-2.83-5.05%
HCMHutchison China Medi...-0.15-1.00%
AGIOAgios Pharmaceutical...-1.93-3.97%
SAGESAGE Therapeutics In...-3.64-6.54%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.12
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs